age-related diseases Archives - Sanford Burnham Prebys
Institute News

Caroline Kumsta awarded $2.9M to study how short-term stress improves health and life expectancy

AuthorSusan Gammon
Date

July 11, 2024

By learning how small amounts of stress activate autophagy, researchers may create new approaches to combat age-related disease

Assistant Professor Caroline Kumsta, Ph.D., has been awarded a five-year, $2.9 million grant from the National Institute on Aging (NIA), part of the National Institutes of Health (NIH). The funding will advance research to better understand how the body’s cellular recycling system (autophagy) needs to be activated to produce long-term health benefits.

“This award will enable us to take a deeper dive into the fascinating concept of hormesis, where mild, sublethal stress leads to improved health and a longer lifespan,” says Kumsta. “Our goal with this grant is to learn more about how this is regulated, which may lead to healthier aging and improved treatments for age-related conditions.”

Like many researchers, Kumsta uses C. elegans—a tiny roundworm—as a model organism to reveal important lessons about aging and autophagy. C. elegans is a powerful tool for biological research because it shares many of the same anatomic and cell functions as humans, and their short lifespan (average 17 days) enables researchers to study how genes are activated and measure the effects in just two to three weeks.

Kumsta’s lab has previously shown how brief exposure to heat shock (stress) early in life triggers autophagy, which is crucial for maintaining cellular health and function. They identified two key transcription factors, HLH-30/TFEB and HSF-1, proteins that help turn specific genes on or off, which play a significant role in regulating autophagy and are required for these long-term benefits.

“Next, we aim to pinpoint the exact timing and specific tissues where autophagy must be activated to achieve these long-term health benefits,” says Kumsta. “We will investigate how heat shock affects autophagy-related genes over time and uncover new regulators of HLH-30/TFEB.

“Our preliminary data suggest that certain autophagy genes maintain elevated transcript levels for several days post-heat shock, indicating a sustained beneficial effect. We will use cutting-edge techniques like single-cell RNA sequencing to identify these long-term transcriptional changes and determine their roles in promoting longevity and improved proteostasis,” adds Kumsta.

By understanding the precise spatiotemporal requirements for autophagy activation, Kumsta hopes to develop innovative strategies, such as heat therapy, to enhance cellular health during aging and treat age-related diseases.

The grant, awarded by the National Institute on Aging, is titled, “Hormetic regulation of Autophagy in Aging” R01 AG083373).

Institute News

The Conrad Prebys Foundation fellows take center stage

AuthorGreg Calhoun
Date

May 20, 2024

Following a year of hands-on training and scientific inquiry supported by a generous grant from the Conrad Prebys Foundation, a diverse group of early-career researchers recently presented their promising progress on translational research projects.

Twelve scientists-in-training at Sanford Burnham Prebys presented research updates at the Conrad Prebys Foundation Fellows Symposium on May 14, 2024, at the Institute’s Fishman Auditorium.

The presentations were the culmination of a yearlong educational program at Sanford Burnham Prebys providing early-career scientists with workshops, mentorship and research experiences focused on how to transform research discoveries into new treatments. The Conrad Prebys Foundation provided critical funding for the program as part of the foundation’s mission to increase the diversity of San Diego’s biomedical workforce.

“This truly has been a pioneering program at the Institute,” says Alessandra Sacco, PhD, director of, and professor in, the Development, Aging and Regeneration Program at Sanford Burnham Prebys; and dean of the Institute’s Graduate School of Biomedical Sciences.

The graduate students and postdoctoral fellows selected to participate in the program conducted projects at the Institute’s  Conrad Prebys Center for Chemical Genomics (Prebys Center), the nation’s leading nonprofit drug discovery center. The Prebys Center specializes in finding new medicines for diseases with a substantial unmet medical need.

Conrad Prebys Foundation fellows poster presentations

“Each participant worked with a pair of co-mentors, one in the laboratory and another in the Prebys Center,” adds Sacco. In addition to extensive mentorship, the program included educational sessions about the drug discovery process.
“This program’s multifaceted approach to training and development has been incredibly rewarding,” says Sacco. Before introducing the symposium’s first speaker, Sacco thanked Michael Jackson, PhD, senior vice president of Drug Discovery and Development at the Prebys Center and director of the Institute’s Cancer Molecular Therapeutics Program; Jessica Colomb, associate director of Administration at the Prebys Center; and all the mentors who contributed to the program’s success.

Conrad Prebys Foundation fellows poster presentations

After the conclusion of the fellows’ formal presentations, Lauren Mitchell, MS, program manager for Diversity, Equity, Inclusion and Belonging (DEIB) at Sanford Burnham Prebys, moderated a discussion for fellowship awardees regarding how this training program enriched their skillset, benefited their career development and contributed to their overall sense of belonging and community, among other topics.

The symposium ended with a poster session and reception celebrating the Conrad Prebys Foundation, participants, mentors and contributors.

“I would like to express my utmost gratitude to the Conrad Prebys Foundation for this fellowship,” says Xiuqing Wei, PhD, postdoctoral associate in the lab of Lorenzo Puri, MD, director of, and professor in, the Development, Aging and Regeneration Program at Sanford Burnham Prebys.

Wei adds, “It was a wonderful experience working with my co-mentors on an amazing translational research project.” Wei focused on methods for targeting the abnormal regulation of a key proinflammatory cytokine which is associated with muscle waste under the conditions of nerve injuries and cancer.

The Conrad Prebys Foundation fellows who presented at the symposium were:

Postdoctoral Fellows

  • Merve Demir
    Zhao Lab, Ed Sergienko co-mentor
    “Structural studies of MtCK and GCDH enzyme drug targets”
  • Alicia Llorente Lope
    Emerling Lab, Ian Pass co-mentor
    “Exploring PI5P4Kγ as a novel molecular vulnerability of therapy-resistant breast cancer” 
  • Van Giau Vo
    Huang Lab, TC Chung co-mentor
    “Identifying enhancers of SNX27 to promote neuroprotective pathways in Alzheimer’s disease and Down Syndrome”
  • Xiuqing Wei
    Puri Lab, Anne Bang co-mentor
    “Selective targeting of a pathogenetic IL6-STAT3 feedforward loop activated during denervation and cancer cachexia”

Predoctoral Fellows

  • Michael Alexander Alcaraz
    Adams Lab, Steven Olson co-mentor
    “Activating the NAMPT-NAD+ axis in senescence to target age-associated disease”
  •   Shea Grenier Davis
    Commisso Lab, Steven Olson co-mentor
    “Examining PIKfyve as a potential therapeutic target in pancreatic cancer” 
  • Aditi Pedgaonkar
    Deshpande Lab, Ed Sergienko co-mentor
    “SGF29 as a novel therapeutic target in AML” 
  • Patrick Hagan
    Cosford Lab, Ian Pass co-mentor
    “Discovery and development of novel ATG13 degrading compounds that inhibit autophagy and treat non-small-cell lung cancer” 
  • Texia Loh
    Wang Lab, Ed Sergienko co-mentor
    “Investigating the role of HELLS in mediating resistance to PARP Inhibition in small-cell lung cancer” 
  • Michaela Lynott
    Colas Lab, TC Chung co-mentor
    “Identification of small molecules inhibiting ATF7IP-SETDB1 interacting complex to improve cardiac reprogramming efficiency” 
  • Tatiana Moreno
    Kumsta Lab, Anne Bang co-mentor
    “Identifying TFEB/HLH-30 regulators to modulate autophagy in age-related diseases” 
  • Utkarsha Paithane
    Bagchi Lab, TC Chung co-mentor
    “Identification of small-molecule enhancers of Honeybadger, a novel RAS/MAPK inhibitor”
Institute News

Time to talk about aging research

AuthorGreg Calhoun
Date

February 29, 2024

Hundreds of scientists gather in San Diego and virtually to share knowledge on the science of aging

For scientists in San Diego and across the United States, March 6-7, 2024, is an important time to talk about developments in aging research. To kick off two scientific meetings on the subject, the NIH-funded San Diego Nathan Shock Center, a collaboration among the Salk Institute for Biological Studies, Sanford Burnham Prebys and the University of California San Diego, will host its 2024 symposium focused on the center’s primary research area, “The Heterogeneity of Aging,” on Wednesday, March 6 at the Salk Institute for Biological Studies in the Conrad T. Prebys Auditorium in La Jolla.

Just as people and organisms age at different rates, scientists have demonstrated that tissues also age at their own speeds – even some cells within tissues age at a unique pace. This phenomenon, known as heterogeneity of aging, is of great interest to researchers as it may hold clues for how to develop interventions that enable people to lead healthier lives as they age. to discuss this topic.

Caroline Kumsta, PhD, assistant professor in the Development, Aging and Regeneration Program at Sanford Burnham Prebys and associate dean of student affairs of the Institute’s Graduate School of Biomedical Sciences, will speak at the 2024 symposium about heterogeneity of aging within the process cells use to recycle or dispose of damaged DNA and other waste products. Kumsta recently coauthored a manuscript in Nature Aging that found new functions for genes involved in this waste management process, known as autophagy. Gaining a better understanding of autophagy is important as scientists have demonstrated that autophagy genes are responsible for prolonged life span in a variety of long-lived organisms. Kumsta received a pilot award from the San Diego Nathan Shock Center in 2022 to support her research on the subject.

“We’re excited to once again offer the La Jolla Aging Meeting on the next day, as we have found that many people like to attend both, and that both meetings help each other,” says Alessandra Sacco, PhD, cohost of both events, director of and professor in the Development, Aging and Regeneration Program at Sanford Burnham Prebys, and dean of the Institute’s Graduate School of Biomedical Sciences.

The 7th annual La Jolla Aging Meeting will be held on Thursday, March 7, also in Salk’s Conrad T. Prebys Auditorium. The meeting was organized by Sacco and Peter Adams, PhD, director of and professor in the Cancer Genome and Epigenetics Program at Sanford Burnham Prebys, and by Jan Karlseder, PhD, Donald and Darlene Shiley Chair, senior vice president and chief science officer at the Salk Institute. The event features mostly short talks from San Diego-based postdoctoral fellows and students researching the biology of aging. The meeting’s goal is to enable participants to meet other researchers and start new collaborations.

“The La Jolla Aging Meeting has more of a focus on early career development, so the events complement each other very well,” adds Sacco.

Three members of Sanford Burnham Prebys will be presenting at the La Jolla Aging Meeting, including Xiao Tian, PhD, who recently joined the Institute as an assistant professor in the Degenerative Diseases Program. Tian focuses on epigenomic changes and deterioration that influence age-related diseases by studying the remarkable traits of naked mole rats: They rarely get cancer. They are resistant to some types of pain. They can survive up to 18 minutes without oxygen. And compared to their rodent peers, naked mole rats age very slowly. Tian’s goal is to unravel the molecular basis of aging and develop strategies to promote a healthier, more vital lifespan.

Last year, more than 400 academics, students and trainees at every career stage gathered in person and virtually from 20 states and several countries to participate in the San Diego Nathan Shock Center “The Heterogeneity of Aging” Symposium and the La Jolla Aging Meeting.

About the San Diego Nathan Shock Center
The San Diego Nathan Shock Center (SD-NSC), led by Gerald Shadel, PhD, Audrey Geisel Chair in Biomedical Science and professor in the Molecular and Cell Biology Laboratory at the Salk Institute, was established in the fall of 2020 with the overall goal of understanding the heterogeneity of aging in order to allow development of personalized interventions to increase the number of years of healthy life. To this end, the center provides three novel scientific Research Resource Cores to develop new human cell models of aging and enable the integrated analysis of molecular, cellular and tissue heterogeneity. The SD-NSC also supports and advocates basic biology of aging research in general through the development, training and mentoring activities of a Research Development Core and robust outreach efforts. All of these activities are accomplished via a consortium of three premier research institutions on the La Jolla Research Mesa: the Salk Institute for Biological Studies, Sanford Burnham Prebys and the University of California San Diego.

Alessandra Sacco serves as director of the SD-NSC Research Development Core and Peter Adams serves as codirector of the SD-NSC Heterogeneity of Aging Core.

Institute News

New roles for autophagy genes in cellular waste management and aging

AuthorCommunications
Date

January 3, 2024

Autophagy genes help extrude protein aggregates from neurons in the nematode C. elegans.

Autophagy, which declines with age, may hold more mysteries than researchers previously suspected. In the January 4 issue of Nature Aging, it was noted that scientists from the Buck Institute, Sanford Burnham Prebys and Rutgers University have uncovered possible novel functions for various autophagy genes, which may control different forms of disposal including misfolded proteins—and ultimately affect aging.

“While this is very basic research, this work is a reminder that it is critical for us to understand whether we have the whole story about the different genes that have been related to aging or age-related diseases,” said Professor Malene Hansen, PhD, Buck’s chief scientific officer, who is also the study’s co-senior author. “If the mechanism we found is conserved in other organisms, we speculate that it may play a broader role in aging than has been previously appreciated and may provide a method to improve life span.”

These new observations provide another perspective to what was traditionally thought to be occurring during autophagy.

Autophagy is a cellular “housekeeping” process that promotes health by recycling or disposing of damaged DNA and RNA and other cellular components in a multi-step degradative process. It has been shown to be a key player in preventing aging and diseases of aging, including cancer, cardiovascular disease, diabetes and neurodegeneration. Notably, research has shown that autophagy genes are responsible for prolonged life span in a variety of long-lived organisms.

The classical explanation of how autophagy works is that the cellular “garbage” to be dealt with is sequestered in a membrane-surrounded vesicle, and ultimately delivered to lysosomes for degradation. However, Hansen, who has studied the role of autophagy in aging for most of her career, was intrigued by an accumulation of evidence that indicated that this was not the only process in which autophagy genes can function.

“There had been this growing notion over the last few years that genes in the early steps of autophagy were ‘moonlighting’ in processes outside of this classical lysosomal degradation,” she said. “Additionally, while it is known that multiple autophagy genes are required for increased life span, the tissue-specific roles of specific autophagy genes are not well defined.”

To comprehensively investigate the role that autophagy genes play in neurons—a key cell type for neurodegenerative diseases—the team analyzed Caenorhabditis elegans, a tiny worm that is frequently used to model the genetics of aging and which has a very well-studied nervous system. The researchers specifically inhibited autophagy genes functioning at each step of the process in the neurons of the animals, and found that neuronal inhibition of early-acting, but not late-acting, autophagy genes, extended life span.

An unexpected aspect was that this life span extension was accompanied by a reduction in aggregated protein in the neurons (an increase is associated with Huntington’s disease, for example), and an increase in the formation of so-called exophers. These giant vesicles extruded from neurons were identified in 2017 by Monica Driscoll, PhD, a collaborator and professor at Rutgers University.

“Exophers are thought to be essentially another cellular garbage disposal method, a mega-bag of trash,” said Caroline Kumsta, PhD, co-senior author and assistant professor at Sanford Burnham Prebys “When there is either too much trash accumulating in neurons, or when the normal ‘in-house’ garbage disposal system is broken, the cellular waste is then being thrown out in these exophers.

“Interestingly, worms that formed exophers had reduced protein aggregation and lived significantly longer. This finding suggests a link between this process of this massive disposal event to overall health,” said Kumsta. The team found that this process was dependent on a protein called ATG-16.2.

The study identified several new functions for the autophagy protein ATG-16.2, including in exopher formation and life span determination, which led the team to speculate that this protein plays a nontraditional and unexpected role in the aging process. If this same mechanism is operating in other organisms, it may provide a method of manipulating autophagy genes to improve neuronal health and increase life span.

“But first we have to learn more—especially how ATG-16.2 is regulated and whether it is relevant in a broader sense, in other tissues and other species,” Hansen said. The Hansen and Kumsta teams are planning on following up with a number of longevity models, including nematodes, mammalian cell cultures, human blood and mice.

“Learning if there are multiple functions around autophagy genes like ATG-16.2 is going to be super important in developing potential therapies,” Kumsta said. “It is currently very basic biology, but that is where we are in terms of knowing what those genes do.”

The traditional explanation that aging and autophagy are linked because of lysosomal degradation may need to expand to include additional pathways, which would have to be targeted differently to address the diseases and the problems that are associated with that. “It will be important to know either way,” Hansen said. “The implications of such additional functions may hold a potential paradigm shift.” 
 
DOI: 10.1038/s43587-023-00548-1

Institute News

Top Sanford Burnham Prebys research stories of 2021

AuthorSusan Gammon
Date

December 14, 2021

This year’s most popular research stories include scientific breakthroughs in COVID-19, cancer, schizophrenia and more.

As we bid farewell to 2021, let’s celebrate our most newsworthy research breakthroughs. Despite the continuing challenges brought on by COVID-19, Sanford Burnham Prebys achieved important milestones on the frontiers of biomedical science.

The following 10 research-related stories received top views on Newswise—the press release distribution service for journalists seeking health and science news.

  1. COVID-19: Scientists identify human genes that fight infection
    A research team was able to pinpoint specific human genes that control viral infection. The information sheds new light on factors that lead to severe disease and guides therapeutic options.
  2. Tumor marker may help overcome endocrine treatment-resistant breast cancer
    The study discovered a new approach to select breast cancer patients for HER2 therapy and could help individuals avoid disease relapse or progression of endocrine-sensitive disease.
  3. Scientists identify potential drug candidates for deadly pediatric leukemia
    Two existing drugs—JAK inhibitors and Mepron—show promise for a subtype of acute myeloid leukemia (AML) that is more common in children. The drugs are proven safe in humans, which could accelerate clinical studies.
  4. Leprosy drug holds promise as at-home treatment for COVID-19
    Scientists found that the leprosy drug clofazimine, which is FDA approved and on the World Health Organization’s List of Essential Medicines, exhibits potent antiviral activities against SARS-CoV-2, and could become an important weapon against future pandemics.
  5. Researchers dig deeper into how cells transport their waste for recycling
    Research describing how the “trash bags” in a cell—called autophagosomes—are tagged for recycling opened new paths to understand age-related diseases such as cancer and neurological disorders. 
  6. New drug combination shows promise as powerful treatment for AML
    Researchers identified two drugs that are potent against acute myeloid leukemia (AML) when combined, but only weakly effective when used alone. The study provides a scientific rationale for advancing clinical studies of the drug combination. 
  7. Biomarker could help diagnose schizophrenia at an early age
    A study described how elevated levels of a protein called CRMP2—found in the brain and blood—could become a format for a rapid, minimally invasive blood test to support the diagnosis of schizophrenia.
  8. Scientists identify “immune cop” that detects SARS-CoV-2
    Researchers discovered the sensor in human lungs that detects SARS-CoV-2 and signals that it’s time to mount an antiviral attack. The sensor activates interferon, the body’s own frontline defender against viral invasion.
  9. Study finds promising therapeutic target for colitis
    Scientists identified an enzyme in the gut that triggers an inflammatory cascade leading to colitis. Therapeutically targeting the enzyme may be a viable approach to help the millions of people worldwide affected by the disorder.
  10. Scientists shrink pancreatic tumors by starving their cellular “neighbors”
    For the first time, blocking “cell drinking,” or micropinocytosis in the thick tissue surrounding a pancreatic tumor, was shown to slow tumor growth—providing more evidence that micropinocytosis is an important therapeutic target.
Institute News

How misplaced DNA contributes to chronic illness

AuthorMiles Martin
Date

October 28, 2021

Though DNA is essential for life, it can also wreak havoc on our bodies as we age 

DNA is one of the essential building blocks of life, giving our cells instructions for virtually everything they do, but researchers at Sanford Burnham Prebys are investigating what happens to our cells when DNA ends up in places where it shouldn’t normally be, particularly as we age.

The answer – as described in their recent review in the journal Cell—is disease-causing inflammation. And the researchers hope that targeting this rogue DNA will lead to new therapeutic strategies for a range of age-related illnesses, including cancer, diabetes, rheumatoid arthritis, cardiovascular disease and neurodegenerative disorders.

“Age is the primary risk factor for all of these diseases, but they share another risk factor – chronic inflammation,” says first author Karl Miller, PhD, a postdoctoral researcher in the lab of Peter Adams, PhD, Sanford Burnham Prebys. “We’re trying to understand the underlying processes behind this inflammation so we can potentially treat all these age-related diseases together”

Typically, cells have DNA safely sequestered in their nucleus and in the mitochondria, where the DNA can do its job without interfering with the rest of the cells’ activities. When cells detect DNA in other areas, they unleash a series of biochemical responses designed to protect the cell from invaders. This response is a component of the innate immune system, our body’s first line of defense against infection.

Scientists have known about this system for decades, but until recently it was mostly thought to respond to foreign DNA, such as during a bacterial or viral infection. However, over the last decade, researchers have discovered that pieces of our own DNA, called endogenous cytoplasmic DNA, can escape from the nucleus or mitochondria and trigger this inflammatory response in our own cells, even in the absence of infection. The resulting ‘sterile’ inflammation can accumulate over time, contributing to a range of age-related diseases in all systems of the body.

But this inflammation is not without its upsides. Cytoplasmic DNA is actually an important short-term protective strategy against cancer formation. The inflammation can alert the immune system at the first sign of cancer, preventing its formation. But over the long term, the sterile inflammation caused by cytoplasmic DNA is also thought to contribute to cancer risk. In fact, we’ve only been able to observe the damage associated with sterile inflammation because people are now living long enough to experience it. 

“Systems like this exist because they’re beneficial in youth, but as we age, they break down,” says Miller. “100 years ago, a lot more people died from infectious diseases early in life. Over time, we’ve become better and better at treating these acute infections, and we’re living much longer. It’s in this later period in life that we see chronic diseases emerging that used to be much less common.”

Miller’s review describes four different types of cytoplasmic DNA fragments, classified according to when and how they appear. Some arise from the nucleus during mistakes in cell division. Others emerge because of errors in DNA repair or replication. Some even escape from mitochondria—energy-producing parts of the cell that have their own separate DNA. Others still are of unknown origin.

“They all look similar under a microscope, and they all can cause similar effects. That’s one of the major problems in this field. The benefit of studying how the different types emerge is that it gives us more points to target for therapeutics,” says Miller. 

In the Adams Lab, Miller and his colleagues look specifically at cytoplasmic chromatin fragments, one of the four types of cytoplasmic DNA. These fragments appear in the cell when the membrane surrounding the nucleus is weakened by senescence, a cellular stress response. Senescence is also associated with aging. 

“We’ve shown how this pathway works in mice, and now we’re actually moving forward with therapeutic applications for humans by doing drug screening to find compounds that can target it,” adds Miller. 

And while there is still a lot of work left for the researchers, their progress is encouraging. Adams, senior author on the Cell review, was recently awarded a $13 million grant by the NIH to study the effects of aging, including the role of cytoplasmic DNA, on the progression of liver cancer. 

“We like to call what we’re doing here ‘increasing the healthspan’, as opposed to the lifespan,” says Miller. “We’re hoping to maximize the healthy period of people’s lives.” 

Institute News

Sanford Burnham Prebys welcomes U.S. Congressman Mike Levin

AuthorMonica May
Date

October 22, 2019

On October 1, 2019, U.S. Representative Mike Levin (D-CA) toured Sanford Burnham Prebys and met with several faculty members to learn more about the innovative biomedical research taking place in his backyard. Levin represents California’s 49th Congressional District, which includes North County San Diego, South Orange County and neighbors our La Jolla campus. 

The visit kicked off with a visit to a lab working to find medicines for a heart arrhythmia condition called atrial fibrillation (AFib), a disorder that hits home for Levin: His grandmother struggled with the disease. Levin peered into a microscope to view beating heart cells and learned how a team of experts from Sanford Burnham Prebys and Scripps Clinic are working to develop personalized treatments for the condition, which affects nearly six million Americans (meet the A-team.)

“Sanford Burnham Prebys is a great example of the vibrant biomedical research taking place in San Diego that has the potential to improve the quality of life for families across the country,” says Levin. “Seeing the Institute’s critical research up close and hearing firsthand how National Institutes of Health (NIH) funding has accelerated medical discovery only strengthens my commitment to supporting biomedical science. Following my visit to Sanford Burnham Prebys, I was proud to introduce legislation that would invest $10 billion in the NIH to support biomedical research, and I will continue to fight for this much-needed funding.”

Following the lab tour, Levin met with faculty members who—thanks to federally funded research—are working to find treatments for Alzheimer’s disease and addiction, and study the aging process to address age-related diseases such as cancer. The visit wrapped up in the lab of Hudson Freeze, PhD, the director of our Human Genetics Program, who studies a rare childhood disease called congenital disorders of glycosylation, or CDG. 

“Americans today are living longer and healthier lives because of federally funded medical research,” says Chris Larson, PhD, the adjunct associate professor of Development, Aging and Regeneration at the Institute who arranged the visit. “We are grateful that Mike took the time to sit down with us to learn about our NIH-funded work and how he can help support us on our mission to find cures for human disease.”

Editor’s note: Shortly after his visit Levin introduced legislation that calls for a $10 billion investment in biomedical research. 

Institute News

The slow, silent process of “inflammaging” might kill you

AuthorSusan Gammon
Date

October 5, 2017

You may recall from biology classes that most DNA is located in the nucleus, the cell’s command center that dictates cell growth, maturation, division and even cell death.  But occasionally, in aging cells that stop growing and dividing (senescent cells), bits of DNA pinch off and accumulate in the cytoplasm.  Although this may seem like an innocent act, cytoplasmic DNA actually triggers an inflammatory path that contributes to many diseases linked with aging.

“We are studying the mechanics of “inflammaging,” says Peter Adams, PhD, professor at SBP.  “The term refers to the pervasive, chronic inflammation that occurs in aging tissue. Understanding how inflammation occurs in aging tissue opens new avenues to treat a variety of age-related diseases such as rheumatoid arthritis, liver disease, atherosclerosis, muscle wasting (sarcopenia), and even cancer.”

Adams’ most recent study, a collaboration with Shelley Berger, PhD, professor at University of Pennsylvania, studied senescent cells to figure out how cytoplasmic DNA activates inflammation.  Senescent cells can be long-lived and accumulate in aged and damaged organs, attracting inflammatory cells that promote tissue damage.

Their new research, published in Nature, is the first to describe how in senescent cells, cytoplasmic DNA fragments activate the cGAS-STING pathway, a component of the immune system that leads to the secretion of pro-inflammatory cytokines.  

“Pro-inflammatory cytokines, such as interferon and tumor necrosis factor (TNF) promote inflammation, which can be a good thing when you need it,” explains Adams.  “Acute inflammation, for example, is a natural, healthy process that attracts and activates immune cells to heal wounds and fight infections.  And in the right circumstances, when our immune system recognizes cancer cells as foreign, these cytokines can activate powerful anti-tumor immune responses.

“But chronic, uncontrolled inflammation is a potentially harmful process.  It can lead to the destruction of tissue, and a list of diseases that range from skin conditions like psoriasis to deadly liver cancer.  So the inflammatory process must be tightly regulated to avoid excessive tissue damage and spillover to normal tissue—and these risks increase with age.

“Now that we understand how cytoplasmic DNA leads to chronic inflammation in senescent cells—through the cGAS-STING pathway—we have the opportunity to think about therapeutic strategies to intervene to delay or prevent “inflammaging” related diseases.

DOI: 10.1038/nature24050

Related: Cancer biology: Genome jail-break triggers lockdown (Nature Magazine)

 

 

Institute News

Fine-tuning cellular energy increases longevity

AuthorJessica Moore
Date

February 25, 2016

New research from SBP has identified a protein that can extend the natural lifespan of C. elegans, a microscopic roundworm commonly used for research on aging and longevity. The findings, published in Cell Reports, expand what we know about the aging process and may lead to new ways to delay the onset of human age-related diseases such as cancer and neurodegenerative diseases. Continue reading “Fine-tuning cellular energy increases longevity”

Institute News

Molecular “brake” prevents excessive inflammation

AuthorGuest Blogger
Date

February 25, 2016

Inflammation is a catch-22: the body needs it to eliminate invasive organisms and foreign irritants, but excessive inflammation can harm healthy cells, contributing to aging and sometimes leading to organ failure and death. A study published in Cell, co-authored by Jorge Moscat, PhD, and Maria Diaz-Meco, PhD, professors in SBP’s NCI-designated Cancer Center, in collaboration with the laboratory of Michael Karin, PhD, at the University of California, San Diego School of Medicine, shows that a protein known as p62 acts as a molecular brake to keep inflammation in check and avoid collateral damage. Continue reading “Molecular “brake” prevents excessive inflammation”